The successful candidate will join Dr. Patrick Worth’s lab with the goal of understanding the cellular, immunologic, and molecular mechanisms of rapid recurrence of pancreatic cancer. He has identified molecular signatures that are common to patients experiencing rapid recurrence in the absence of identifiable disease prior to surgery. He has further demonstrated that patients experience rapid recurrence of pancreatic cancer irrespective of receipt of neoadjuvant therapy, completion of adjuvant therapy, or postoperative complications, further pointing to biological differences.
In an effort to further model the processes by which pancreatic cancer recurs after surgery, he has developed a mouse model of post-surgical rrPDAc. His lab is funded through an Idea Development Award from the Department of Defense, as well as start-up funding from the Department of Surgery. Dr. Worth is an inaugural recipient of the NIH’s Early-stage Surgeon Scientist Program Award.
The Research Associate will be responsible for most of the planning, implementation, and data interpretation associated with their own research. Additionally, the successful candidate is expected to interact with graduate students and research assistants/technicians and be actively involved in their scientific supervision and in the general research directions of the lab (both technically and intellectually).
A critical aspect of this position is to establish and maintain collaborations by taking full advantage of the terrific network of labs offered within OHSU, including the Brenden Colson Center for Pancreatic Care, the Sears Lab, the Dept. of Surgery, as well as the Knight Cancer Institute. Duties include:
Apply here online. Please be sure to upload a cover letter and CV.